Mid South Essex GP FAQs

Community Health & Eye Care logo
  • What is the correct referral route for MSE Community Dermatology SPOA from 1 February 2026?Chevron

     All adult dermatology referrals must be submitted electronically via the eRS Single Point of Access (SPOA) – MSE Community Dermatology Single Point of Access – RAS (K4R3Z)

    Adult dermatology USC referrals sent directly to secondary care will no longer be accepted and following a period of transition routine referrals will also no longer be accepted.

  • To refer to the MSE Community Dermatology SPOA service on eRS, please follow the steps below on eRS: 

    • select specialty as ‘Dermatology’ : 
    • Please select one of the following Clinic Types:  

    Press Search for the MSE Community Dermatology Single Point of Access – RAS (K4R3Z) service to be listed.

  • A standard referral form will be used for primary care referrals which will include a minimum data set. All referrals should be sent electronically using the eRS.

  • Yes, CHEC will work to ensure the safe and secure transfer of all referrals. 

  • Yes. Routine referrals are triaged within 2 working days, and USC referrals within 1 working day, to determine the best clinical pathway (e.g., teledermatology or in-person), and to ensure patient are seen by the right service at the right time.  All referrals are triaged by the CHEC dermatology clinical team. 

  • Following clinical triage any referrals assessed as inappropriate for community dermatology, in line with the MSE Levels of Care (developed and agreed by clinicians across primary, community and secondary care), will be either returned back to the referring GP with advice and  guidance, or referred onwards to the secondary care provider of choice for further assessment and treatment. 

  • The MSE Community Dermatology Single Point of Access (SPOA) Service provides a single adult dermatology pathway for all conditions, including skin lesions, rashes, inflammatory conditions, and Urgent Suspected Cancer (USC).

    Clinical offer will remain in line with the MSE Levels of Care developed and agreed by clinicians across primary, community and secondary care.

    • Aged under 16 years 
    • Non-Dermatological conditions 
    • Cosmetic procedures listed in the ICB Service Restriction Policy including scar revision, tattoo removal, birthmark removal, turnable dye laser and excision of benign skin lesions 
  • MSE Community Dermatology Single Point of Access (SPOA) Service will provide assessment and treatment to new referrals; the follow up appointment will be arranged in line with the patients’ clinical needs.  

    Patient initiated follow-up (PIFU) will be considered when clinically appropriate for service users following a shared decision-making process with individual service users.   

  • Yes. MSE Community Dermatology SPOA will work seamlessly with Mid and South Essex NHS Foundation Trust (MSEFT) in the delivery of the urgent suspected cancer pathway across mid and south Essex. Referrals sent directly to secondary care will no longer be accepted.

    All adult USC dermatology referrals must be submitted via the Single Point of Access (SPOA).

    Urgent Suspected Cancer referrals will undergo initial triage within one working day. Urgent Suspected Cancer referrals that are not suitable for teledermatology will be referred directly on to Mid and South Essex NHS Foundation Trust (MSEFT).

  • The service covers the following: 

    • Mild to Moderate Eczema 
    • Mild to moderate Psoriasis < 10% of body 
    • Rash or lesion of diagnostic uncertainty 
    • Mild to Moderate/Severe Acne 
    • Actinic Keratosis 
    • Urticaria 
    • Rosacea 
    • Pruritis 
    • Symptomatic benign lesions on the face, e.g., seborrhoeic keratoses or epidermoid cysts 
    • Bowen’s disease 
    • BCCs – excluding those on the face 
    • Infection + infestations, e.g., tinea 
    • Lichen planus and other inflammatory disorders 
    • Pigment disorders, e.g., vitiligo 
    • Alopecia/hair loss 
    • Hirsutism* 
    • Hair/nail/scalp disorders 
    • Rashes of diagnostic uncertainty* 
    • Keloid scars 
    • Hidradenitis suppurativa 
    • Pyogenic granulomas 
    • Skin Biopsies 
    • Leg Ulcer and Tissue Viability 

    * Very specialised areas 

  • Yes, MSE Community Dermatology SPOA will undertake minor surgical procedures in line with the agreed MSE Levels of Care. This will include, but is not limited to removal of skin lesions, where the ICB Service Restriction Policy criteria is met.  The service will not undertake minor ops that form part of primary care services.

  • Patients assessed as suitable for discharge back to their GP, in line with the agreed MSE Levels of Care, will receive an appropriate discharge letter. For those requiring an ongoing management plan or advice and guidance, this information will be communicated directly to the GP.

  • The patients requiring face to face assessment or minor surgical procedures will be offered a choice of MSE Community Dermatology SPOA community locations within Mid and South Essex ICS boundaries: 

    Audley Mills Surgery, 57 Eastwood Road, Rayleigh, SS6 7JF 

    Benfleet Clinic, 513 High Road, Benfleet, Essex, SS7 5AD 

    Billericay Medical Centre, Stock Road, Billericay, CM12 0BJ 

    Brentwood Community Hospital, 11 Crescent Drive, Shenfield, Brentwood, CM15 8DR 

    Leigh Primary Care Centre, 918 London Road, Southend-on-Sea, Leigh-on-Sea, SS9 3NG 

    Manor Street Health Hub, Manor Street, Braintree, CM7 3HP 

    Thurrock Health Centre, 55-57 High Street, Grays, RM17 6NB 

    Valkyrie Primary Care Centre, 50 Valkyrie Rod, Westcliffe-on-Sea, SS0 8BU 

    In addition, suitable sites are currently being identified in the Maldon area. 

  • Following initial triage, clinically suitable patients will be offered a virtual teledermatology assessment conducted by consultant dermatologists. The patient will receive a communication from the MSE Community Dermatology SPOA requesting the completion of a clinical questionnaire and the submission of images of their condition. These images and details will be reviewed by a consultant dermatologist, who will then communicate the outcome, diagnosis, and management plan—including any prescribed medication—to both the patient and their GP.

  • Monday to Friday 0800-1800

  • Phone number: 0344 264 4160 

    Email: dermatology.ent1@nhs.net 

  • Urgent Suspected Cancer referrals will undergo initial triage within one working day. Urgent Suspected Cancer referrals that are not suitable for teledermatology will be referred directly on to Mid and South Essex NHS Foundation Trust (MSEFT).  

    Routine referrals will undergo initial triage within two working days. 

  • Yes, the MSE Community Dermatology Single Point of Access (SPOA) Service will provide electronic advice and guidance support to primary care. All advice and guidance requests will be responded to within two working days.

    The MSE Community Dermatology Single Point of Access (SPOA) Service will also be able to send advice and guidance requests to secondary care via eRS for support with on-going management of service users.

  • Yes. Referrals are accepted with or without macroscopic and dermoscopic images. Where available GPs should use macroscopic and dermoscopic images captured in primary care.

  • Both macroscopic and dermoscopic images are supported. If a GP cannot provide them, patients can be supported to submit their own via MySkinDoctor or attend a Community Image Hub

  • Yes, teledermatology is a core component used for rapid diagnostics and virtual consultations via a digital MySkinDoctor app.  Following image review, if patients require face to face assessment in the community they will continue within the service.  If the patient requires onward referral to secondary care, CHEC will provide the patient choice of acute provider in line with the Patient Choice Policy. 

  • If a patient (including USC) is deemed unsuitable for the community teledermatology pathway during triage, the MSE Community Dermatology Single Point of Access (SPOA) Service will refer them to their choice of acute provider for routine referrals and directly to MSEFT for USC referrals.

  • Yes, if the patient requires onward referral to secondary care under the routine pathway, CHEC will provide the patient choice of acute provider in line with the Patient Choice Policy and refer them to the appropriate service.    

  • The MSE Community Dermatology Single Point of Access (SPOA) Service will provide clear communication between referring and receiving clinicians, integrated with existing clinical systems to support safe workflows. 

  • Yes. Following the community dermatology assessment, consultation outcomes are sent to both the GP and the patient within five working days. These documents will clearly outline the management plan and any medications prescribed, including whether repeat prescriptions are required.

  • Yes, a discharge summary will be sent to the GP and patient within three working days following the assessment. 

  • Any clinician enquiries regarding dermatology referrals should be directed to dermatology.ent1@nhs.net

CHEC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Further information can be found in our Privacy Policy and Cookie Policy.